New York S 8367: Relates to capping cost sharing for antiviral COVID-19 therapeutics

Status: REFERRED TO INSURANCE (as of 2024-06-05)

State: New York · Session: 2023-2024 · Bill: S 8367

Sponsors: Brad Hoylman-Sigal

View New York S 8367 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.